ATTO · Company research
Attovia Therapeutics, Inc. Common Stock (ATTO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Attovia Therapeutics, Inc. (NASDAQ:ATTO) Stock Short Interest Report for September - MarketBeat | Attovia Therapeutics, Inc. (NASDAQ:ATTO) Stock Short Interest Report for September MarketBeat | View source ↗ | MarketBeat | Oct 14, 2026 | neutral | 0 | 0.6 |
| This small EV is Australia's equal-cheapest car, but not forever - Drive | This small EV is Australia's equal-cheapest car, but not forever Drive | View source ↗ | Drive | Oct 10, 2026 | neutral | 0 | 0.6 |
| This small EV is Australia's equal-cheapest car, but not forever - caradvice.com.au | This small EV is Australia's equal-cheapest car, but not forever caradvice.com.au | View source ↗ | caradvice.com.au | Oct 10, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics (ATTO) amends CFO option-grant report with no ownership changes. - Stock Titan | Attovia Therapeutics (ATTO) amends CFO option-grant report with no ownership changes. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| No ownership changes: Attovia Therapeutics (ATTO) CEO Tao Fu reports 87,843 direct shares. - Stock Titan | No ownership changes: Attovia Therapeutics (ATTO) CEO Tao Fu reports 87,843 direct shares. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics (Nasdaq:ATTO) - Stock Analysis - Simply Wall Street | Attovia Therapeutics (Nasdaq:ATTO) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 7, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics stock heads into October 8 data presentations - AD HOC NEWS | Attovia Therapeutics stock heads into October 8 data presentations AD HOC NEWS | View source ↗ | AD HOC NEWS | Oct 5, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics Inc (ATTO-Q) Stock Price and News - The Globe and Mail | Attovia Therapeutics Inc (ATTO-Q) Stock Price and News The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics (ATTO) Stock News - Stock Titan | Attovia Therapeutics (ATTO) Stock News Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics (ATTO) Stock Chart and Price History 2026 $ATTO - MarketBeat | Attovia Therapeutics (ATTO) Stock Chart and Price History 2026 $ATTO MarketBeat | View source ↗ | MarketBeat | Aug 7, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics (ATTO) 10K Form and Latest SEC Filings 2026 - MarketBeat | Attovia Therapeutics (ATTO) 10K Form and Latest SEC Filings 2026 MarketBeat | View source ↗ | MarketBeat | Aug 7, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: 10% owner at $ATTO Buys 300,000 Shares - Quiver Quantitative | Insider Purchase: 10% owner at $ATTO Buys 300,000 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 7, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics, Inc. Common Stock (ATTO) Stock Price: Oct 9 Close $16.21 - Gotrade | Attovia Therapeutics, Inc. Common Stock (ATTO) Stock Price: Oct 9 Close $16.21 Gotrade | View source ↗ | Gotrade | Aug 6, 2026 | neutral | 0 | 0.6 |
| Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO - Fierce Biotech | Attovia's CEO aims to scratch itch opportunity and challenge Dupixent with $289M IPO Fierce Biotech | View source ↗ | Fierce Biotech | Aug 5, 2026 | neutral | 0 | 0.6 |
| Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders - MedCity News | Attovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders MedCity News | View source ↗ | MedCity News | Aug 5, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics Prices Upsized $289 Million Initial Public Offering - Quiver Quantitative | Attovia Therapeutics Prices Upsized $289 Million Initial Public Offering Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 5, 2026 | neutral | 0 | 0.6 |
| Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering - Yahoo Finance Singapore | Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Aug 4, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jul 31, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.